CDT Equity Inc. SEC filings CDT
CDT Equity Inc. has 368 filings in SEC EDGAR's recent list, going back to Dec 9, 2021. Its latest annual report, Form ARS, was filed on Aug 11, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (change to shareholder rights, bylaw or fiscal year change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Sep 17, 2026 | — |
| NT 10-Q | Filing | May 15, 2026 | Mar 31, 2026 |
| EFFECT | Filing | May 1, 2026 | — |
| CORRESP | Letter to the SEC | Apr 30, 2026 | — |
| UPLOAD | Letter from the SEC | Apr 29, 2026 | — |
| NT 10-K | Filing | Apr 1, 2026 | Dec 31, 2025 |
| EFFECT | Filing | Feb 9, 2026 | — |
| CORRESP | Letter to the SEC | Feb 6, 2026 | — |
| UPLOAD | Letter from the SEC | Feb 6, 2026 | — |
| EFFECT | Filing | Aug 7, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 5, 2025 | — |
| CORRESP | Letter to the SEC | Aug 5, 2025 | — |
| EFFECT | Filing | Apr 30, 2025 | — |
| CORRESP | Letter to the SEC | Apr 28, 2025 | — |
| UPLOAD | Letter from the SEC | Apr 28, 2025 | — |
| EFFECT | Filing | Feb 12, 2025 | — |
| CORRESP | Letter to the SEC | Feb 11, 2025 | — |
| UPLOAD | Letter from the SEC | Feb 11, 2025 | — |
| EFFECT | Filing | Dec 6, 2024 | — |
| CORRESP | Letter to the SEC | Dec 4, 2024 | — |
| UPLOAD | Letter from the SEC | Dec 2, 2024 | — |
| EFFECT | Filing | Nov 1, 2024 | — |
| CORRESP | Letter to the SEC | Oct 31, 2024 | — |
| UPLOAD | Letter from the SEC | Oct 29, 2024 | — |
| EFFECT | Filing | Sep 16, 2024 | — |
| CORRESP | Letter to the SEC | Sep 16, 2024 | — |
| EFFECT | Filing | May 2, 2024 | — |
| NT 10-K | Filing | Apr 1, 2024 | Dec 31, 2023 |
| EFFECT | Filing | Dec 15, 2023 | — |
| CORRESP | Letter to the SEC | Dec 13, 2023 | — |
| CORRESP | Letter to the SEC | Dec 1, 2023 | — |
| NT 10-Q | Filing | Nov 14, 2023 | Sep 30, 2023 |
| UPLOAD | Letter from the SEC | Oct 30, 2023 | — |
| 25-NSE | Delisting notice | Sep 22, 2023 | — |
| CERT | Filing | Sep 22, 2023 | — |
| 8-A12B | Filing | Sep 22, 2023 | — |
| 425 | Filing | Sep 13, 2023 | — |
| 425 | Filing | Sep 7, 2023 | — |
| 425 | Filing | Aug 31, 2023 | — |
| 425 | Filing | Aug 23, 2023 | — |
| 425 | Filing | Aug 16, 2023 | — |
| SEC STAFF LETTER | Filing | Aug 11, 2023 | — |
| EFFECT | Filing | Aug 11, 2023 | — |
| CORRESP | Letter to the SEC | Aug 10, 2023 | — |
| CORRESP | Letter to the SEC | Aug 8, 2023 | — |
| UPLOAD | Letter from the SEC | Aug 7, 2023 | — |
| CORRESP | Letter to the SEC | Jul 28, 2023 | — |
| 425 | Filing | Jul 21, 2023 | — |
| UPLOAD | Letter from the SEC | Jul 20, 2023 | — |
| CORRESP | Letter to the SEC | Jul 11, 2023 | — |
| UPLOAD | Letter from the SEC | May 31, 2023 | — |
| SEC STAFF LETTER | Filing | May 30, 2023 | — |
| CORRESP | Letter to the SEC | May 12, 2023 | — |
| 425 | Filing | May 11, 2023 | — |
| UPLOAD | Letter from the SEC | Mar 1, 2023 | — |
| DRS | Filing | Feb 1, 2023 | — |
| 425 | Filing | Jan 30, 2023 | — |
| UPLOAD | Letter from the SEC | Nov 25, 2022 | — |
| CORRESP | Letter to the SEC | Nov 23, 2022 | — |
| UPLOAD | Letter from the SEC | Nov 21, 2022 | — |
| 425 | Filing | Nov 14, 2022 | — |
| 425 | Filing | Nov 8, 2022 | — |
| NT 10-Q | Filing | May 16, 2022 | Mar 31, 2022 |
| EFFECT | Filing | Feb 2, 2022 | — |
| CORRESP | Letter to the SEC | Feb 1, 2022 | — |
| CORRESP | Letter to the SEC | Feb 1, 2022 | — |
| RW WD | Filing | Jan 26, 2022 | — |
| CORRESP | Letter to the SEC | Jan 26, 2022 | — |
| RW | Filing | Jan 26, 2022 | — |
| CERT | Filing | Jan 25, 2022 | — |
| 8-A12B | Filing | Jan 24, 2022 | — |
| CORRESP | Letter to the SEC | Jan 21, 2022 | — |
| CORRESP | Letter to the SEC | Jan 21, 2022 | — |
| UPLOAD | Letter from the SEC | Dec 20, 2021 | — |
| DRS | Filing | Dec 9, 2021 | — |
Showing 75 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CDT (Nasdaq), CDTTW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Naples, FL
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1896212
- Former names
- CONDUIT PHARMACEUTICALS INC. (until Aug 7, 2025); Murphy Canyon Acquisition Corp. (until Sep 21, 2023)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.